Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 63, Issue 19
Displaying 1-27 of 27 articles from this issue
EDITORIAL
ORIGINAL ARTICLES
  • Sho Hitomi, Yorihiko Koeda, Kengo Tosaka, Nozomu Kanehama, Masanobu Ni ...
    2024Volume 63Issue 19 Pages 2595-2603
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    Objective This study examined variations in in-hospital mortality causes and identified independent mortality predictors among patients with acute myocardial infarction (AMI) with and without diabetes mellitus (DM).

    Methods We examined factors influencing in-hospital mortality in a single-center retrospective observational study. Separate multivariate analyses were conducted for both groups to identify independent predictors of in-hospital mortality.

    Patients This study included consecutive patients admitted to Iwate Medical University Hospital between January 2012 and December 2017 with a diagnosis of AMI.

    Results Of 1,140 patients meeting the AMI criteria (average age: 68.2±12.8 years old, 75% men), 408 (35.8%) had diabetes. The DM group had a 1.87-times higher 30-day mortality rate, a lower prevalence of ST-elevated MI (56.6% vs. 65.3% in non-DM, p=0.004), and more frequent non-cardiac causes of death (32% vs. 14% in non-DM, p=0.046) than the non-DM group. Independent predictors of in-hospital mortality in both groups were cardiogenic shock (CS) [DM: hazard ratio (HR) 6.59, 95% confidence interval (CI) 2.90-14.95; non-DM: HR 4.42, 95% CI 1.99-9.77] and renal dysfunction (DM: HR 5.64, 95% CI 1.59-20.04; non-DM: HR 5.92, 95% CI 1.79-19.53). Among patients with DM, a history of stroke was an additional independent predictor of in-hospital mortality (HR 2.59, 95% CI 1.07-6.31).

    Conclusion Notable disparities were identified in the causes of death and predictive factors of mortality between these two groups of patients with AMI. To further improve AMI outcomes, individualized management and prioritizing non-cardiac comorbidities during hospitalization may be crucial, particularly in patients with DM.

    Download PDF (307K)
  • Miki Yarita-Kawana, Satoshi Kidoguchi, Yohei Suehiro, Naoki Sugano, Ta ...
    2024Volume 63Issue 19 Pages 2605-2612
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS
    Supplementary material

    Introduction Primary aldosteronism is characterized by the autonomous excretion of aldosterone, which may induce bone mineral disorders.

    Methods A total of 96 patients with primary aldosteronism were analyzed to identify differences in the regulation of serum calcium/phosphate balance between patients with unilateral and bilateral aldosterone hypersecretion and to determine whether or not adrenalectomy or mineralocorticoid receptor blockers affected such differences.

    Results Serum phosphate concentrations were significantly lower in patients with unilateral aldosterone hypersecretion than in patients with bilateral aldosterone hypersecretion (2.96±0.45 vs. 3.36±0.55 mg/dL, p<0.05), and recovered after adrenalectomy (2.96±0.45 vs. 3.49±0.32 mg/dL, p<0.01). In patients with bilateral aldosterone hypersecretion, the baseline serum phosphate levels were significantly lower in responders to mineralocorticoid receptor blocker treatment, defined as post-treatment plasma renin activity ≥1 ng/mL/h, than in non-responders. In responders, these levels tended to recover after treatment. A weak negative correlation between the plasma aldosterone concentration (PAC) and serum phosphate was observed, but there were no associations between the PAC and serum calcium concentration or between the aldosterone renin ratio and serum calcium and phosphate concentrations.

    Conclusion The effects on calcium/phosphate homeostasis may differ according to the primary aldosteronism subtype.

    Download PDF (324K)
  • Junya Aoki, Kazumi Kimura, on behalf of the ADS investigator
    2024Volume 63Issue 19 Pages 2613-2620
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Objective Although the body mass index (BMI) is considered a meaningful parameter for evaluating obesity, the association between the BMI and acute non-cardioembolic stroke remains unclear. We investigated how the BMI was related to patients' background, type of infarction, and infarction location in patients with non-cardioembolic stroke using an acute dual study (ADS) cohort.

    Methods The ADS trial was conducted between May 2011 and June 2017 in Japan. The BMI classifications were those proposed by the World Health Organization classification: underweight, <18.5 kg/m2; normal weight, 18.5-24.9 kg/m2; overweight, 25-29.9 kg/m2; and obese, ≥30 kg/m2.

    Results Data from 1,136 patients were analyzed. The median BMI was 23.6 kg/m2 (interquartile range: 21.6-25.8 kg/m2), with a BMI ≥30 kg/m2 in 63 patients (6%), 25-29.9 kg/m2 in 321 (28%), 18.5-24.9 kg/m2 in 692 (61%), and <18.5 kg/m2 in 60 (5%). The group with a BMI ≥30 kg/m2 was the youngest, and the group with a BMI <18.5 kg/m2 was the oldest (p<0.001). The proportion of patients with a history of hypertension (p<0.001), diabetes (p<0.001), dyslipidemia (p<0.001), and statin therapy (p=0.005) increased with increasing BMI. Pontine infarcts were frequent in the following order: obese, overweight, normal weight, and underweight (24%, 18%, 14%, and 13%, respectively; p=0.034). In contrast, cortical infarct were frequent in the order of underweight, normal weight, overweight, and obese at 20%, 19%, 14%, and 3%, respectively (p=0.007).

    Conclusion Acute stroke patients with a high BMI have more atherosclerosis-related factors in their backgrounds than those with lower BMIs. In addition, the BMI may be a determinant of infarct location in patients with acute stroke.

    Download PDF (185K)
  • Joe Nemoto, Jun-ichi Ogasawara, Michiaki Koga
    2024Volume 63Issue 19 Pages 2621-2625
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    Objective This study clarified a variety of neurological phenotypes associated with varicella-zoster virus (VZV) reactivation.

    Methods This retrospective single-center study included consecutive patients with herpes zoster accompanied by neurological disturbances from April 2016 to September 2022. A comparative analysis was performed to examine whether or not the neurological phenotype and severity were associated with the distribution of herpes zoster, clinical and laboratory findings, and treatments.

    Results Twenty-six patients with a median age of 74 years old were enrolled. None of the patients had been vaccinated against herpes zoster. Of the 26 patients, 14 (54%) developed monoparesis, 5 (19%) developed meningitis, 5 (19%) developed encephalitis, 1 (4%) developed paraplegia, and 1 (4%) developed bladder and rectal problems. Monoparesis of the upper limb is associated with herpes zoster involving the cervical and thoracic dermatomes, whereas meningitis and encephalitis often occur in patients with herpes zoster in the trigeminal and thoracic dermatomes. Neurological disability was generally severe [modified Rankin Scale (mRS) score ≥3] on admission [17 of 26 (65%) patients]. Good recovery after admission was associated with a lower mRS value before the onset of neurological disability, clinical meningitis, and elevated cell counts and protein levels in the cerebrospinal fluid. Good recoveries were observed in patients with herpes zoster in the trigeminal or thoracic dermatomes more frequently than in other dermatomes.

    Conclusion This study revealed that VZV-related neurological complications are heterogeneous, commonly leading to severe disability and poor outcomes, and that neurological phenotypes and outcomes are related to the distribution of herpes zoster.

    Download PDF (145K)
CASE REPORTS
  • Takashi Ueda, Hirohiko Sato, Takashi Ogimi, Ryuzo Deguchi, Hidekazu Su ...
    2024Volume 63Issue 19 Pages 2626-2630
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 19, 2024
    JOURNAL OPEN ACCESS

    An 87-year-old man experiencing lower abdominal discomfort resulting from the ingestion of a fish bone underwent conservative management involving endoscopic extraction of the fish bone lodged in the sigmoid colon. Most patients with lower gastrointestinal tract perforations typically develop peritonitis or abscesses, necessitating surgical intervention. Notably, endoscopic management of lower gastrointestinal tract perforations is infrequently employed. Patients presenting with localized abdominal symptoms along with a stable overall health condition may benefit from conservative therapeutic approaches that utilize endoscopic methods. Notably, the transition from endoscopic procedures for foreign body removal to surgical intervention requires close collaboration with a surgeon and must be executed judiciously.

    Download PDF (487K)
  • Shinji Unome, Kenji Imai, Takao Miwa, Tatsunori Hanai, Atsushi Suetsug ...
    2024Volume 63Issue 19 Pages 2631-2636
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Combined hepatocellular cholangiocarcinoma is a rare and challenging primary liver malignancy that lacks any established standard treatments for unresectable cases. We herein present the first known case of a 49-year-old woman diagnosed with unresectable combined hepatocellular-cholangiocarcinoma, who underwent novel chemotherapy involving durvalumab plus tremelimumab combination therapy. The treatment was temporarily discontinued owing to immune-related adverse events, such as rash, and the patient was subsequently managed with systemic steroid therapy; however, the disease progressed after two courses of this treatment. Further studies are needed to validate the efficacy and safety of immune checkpoint inhibitors such as durvalumab and tremelimumab for the treatment of unresectable combined hepatocellular cholangiocarcinoma.

    Download PDF (3755K)
  • Hayato Tada, Nobuko Kojima, Akihiro Nomura, Masayuki Takamura
    2024Volume 63Issue 19 Pages 2637-2640
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 19, 2024
    JOURNAL OPEN ACCESS

    We herein report the first family of Japanese individuals with familial hypobetalipoproteinemia caused by the c.1468C>T mutation in apolipoprotein B (APOB). A 13-year-old boy with extremely low levels of low-density lipoprotein (LDL) cholesterol (24 mg/dL) was referred to our hospital. The patient had no secondary causes of hypobetalipoproteinemia. His father and grandmother also exhibited low LDL cholesterol levels. A genetic analysis confirmed that they all had this variant in APOB (c.1468C>T). None of the patients exhibited atherosclerotic cardiovascular diseases or any other complications associated with low LDL cholesterol levels, including fatty liver, neurocognitive disorders, and cerebral hemorrhaging.

    Download PDF (236K)
  • Akiko Tanihata, Atsushi Shibata, Kazutoshi Teragaki, Toshitake Yoshida ...
    2024Volume 63Issue 19 Pages 2641-2646
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    We herein report the case of a 46-year-old woman with Takayasu arteritis (TA), severe stenosis in the left main coronary artery (LMCA), and severe aortic regurgitation. Prednisolone and tacrolimus were initiated as TA treatments. Two months after initiating medical therapy, the aortic regurgitation severity improved to a moderate grade, although there was no obvious improvement in LMCA stenosis. Thus, after confirming the resolution of inflammation, we performed coronary artery bypass grafting alone without any aortic valve intervention. In TA patients with severe LMCA stenosis, surgical management of the coronary artery should therefore be considered only after successfully administering anti-inflammatory therapy.

    Download PDF (1195K)
  • Yuequan Shi, Xiaoxiao Shi, Haiyun Wang, Zijuan Zhou, Lei Zhang, Limeng ...
    2024Volume 63Issue 19 Pages 2647-2650
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 19, 2024
    JOURNAL OPEN ACCESS

    Parvovirus B19 infection can cause chronic pure red cell aplasia in immunosuppressed hosts or acute and transient aplastic crisis in immunocompetent hosts. In dialysis patients, only transient aplastic crisis induced by parvovirus B19 infection has been reported. We herein report the first case of an adult dialysis patient who developed chronic pure red cell aplasia associated with parvovirus B19 infection. Repeated pneumonia and heart failure may contribute to an immunocompromised status, making the patient more vulnerable to parvovirus B19 infection. This case expands on the differential diagnosis of chronic anemia in patients undergoing dialysis.

    Download PDF (360K)
  • Kosuke Mochizuki, Naohiro Toda, Masaaki Fujita, Satoshi Kurahashi, His ...
    2024Volume 63Issue 19 Pages 2651-2654
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    Atypical hemolytic uremic syndrome (aHUS) is a type of HUS. We herein report a case of aHUS triggered by pancreatitis in a patient with a heterozygous variant of membrane cofactor protein (MCP; P165S), a complement-related gene. Plasma exchange therapy and hemodialysis improved thrombocytopenia and anemia without leading to end-stage kidney disease. This MCP heterozygous variant was insufficient to cause aHUS on its own. Pancreatitis, in addition to a genetic background with a MCP heterozygous variant, led to the manifestation of aHUS. This case supports the "multiple hit theory" that several factors are required for the manifestation of aHUS.

    Download PDF (311K)
  • Hiroaki Matsuura, Go Makimoto, Naohiro Oda, Kiichiro Ninomiya, Hisao H ...
    2024Volume 63Issue 19 Pages 2655-2660
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    Nuclear protein of the testis carcinoma (NUTC) is a rare and aggressive malignancy. We herein report a case of NUTC in the lung characterized by a bronchial lesion and elevated alpha-fetoprotein levels. A 35-year-old Japanese man presented to our institution with suspected advanced lung cancer based on a histological examination. Subsequently, next-generation sequencing (NGS) yielded a positive BRD4-NUTM1 fusion. In addition, positive NUT immunostaining of the lung biopsy specimen confirmed NUTC in the lungs. Systemic chemotherapy and radiotherapy showed a temporary response, with decreased serum alpha-fetoprotein levels. We highlight this case of a prompt diagnosis by NGS of NUTC in a young individual with a rapidly progressing tumor.

    Download PDF (1228K)
  • Hikaru Mamizu, Hiroki Kohda, Yuusuke Tomita, Takuma Hatakeyama, Maiko ...
    2024Volume 63Issue 19 Pages 2661-2666
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    Amiodarone, a prominent antiarrhythmic drug, may cause lung injury. We herein report the case of an 87-year-old man who had been taking amiodarone for 5 years and was subsequently referred due to respiratory failure. Chest computed tomography revealed multiple consolidations with air bronchograms in both lungs. Despite administering steroid pulse therapy, his respiratory failure worsened, and he died 3 days later. Autopsy revealed hyaline membrane formation and organic formation with fibrin deposition. Drug-induced lung injury caused by amiodarone was confirmed by autopsy. Caution is therefore required when fibrin deposition in the alveolar spaces is observed in such cases, which are prone to suffer a rapid deterioration.

    Download PDF (2574K)
  • Yuya Yoshida, Sakura Toriyabe, Hiroo Imai, Keiju Sasaki, Yuki Kasahara ...
    2024Volume 63Issue 19 Pages 2667-2671
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Recently, immune checkpoint inhibitors (ICIs) have been used to treat several cancer types. ICIs have been reported to cause a wide variety of immune-related adverse events, including endocrine, neurologic, gastrointestinal, and cutaneous disorders. Thrombotic thrombocytopenic purpura (TTP) is an autoimmune hematologic disorder characterized by the presence of autoantibodies against a disintegrin and metalloprotease with thrombospondin-1, member 13. Several previous cases of TTP were thought to have been caused by ICI treatment. We herein report a rare case of TTP that developed after long-term treatment with an ICI (nivolumab) for gastric tube cancer.

    Download PDF (774K)
  • Tomoaki Shima, Kairi Yamashita, Kanako Furuta, Kohei Tsujino, Saeko Na ...
    2024Volume 63Issue 19 Pages 2673-2677
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    Cases of herpes zoster ophthalmicus (HZO) complicated by bilateral ophthalmoplegia are rare, and no cases of bilateral third, fourth, or sixth cranial nerve palsies have been reported. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a rare complication of HZO. We herein report an 80-year-old Japanese woman with right-sided HZO complicated by meningoencephalitis and discuss the pathogenesis of this condition. She developed bilateral third, fourth, and sixth cranial nerve palsies and SIADH almost simultaneously during treatment for HZO. The bilateral cranial palsy spontaneously resolved within a few months.

    Download PDF (813K)
  • Tsutomu Yasuda, Jun Shimizu, Toji Miyagawa, Yuri Tsutsumi, Takeshi Iwa ...
    2024Volume 63Issue 19 Pages 2679-2682
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    A 77-year-old female with a subacute progression of ataxia and serum anti-Yo antibodies was suspected to have paraneoplastic cerebellar degeneration (PCD). An examination of an underlying cancer showed no abnormality in the gynecological organs, but the findings did show a mass in the Douglas fossa. The mass was resected and diagnosed as stage IIB peritoneal serous papillary carcinoma (PSPC), a rare gynecologic cancer that is difficult to diagnose in the early stages. PCD was treated with intravenous immunoglobulin (IVIG). For an early diagnosis and treatment, PSPC should be included in the list of malignancies that cause PCD with anti-Yo antibodies.

    Download PDF (731K)
  • Tsuyoshi Hamaguchi, Ichizo Nishino, Yasuki Hirano, Nobuaki Uchida, Mic ...
    2024Volume 63Issue 19 Pages 2683-2687
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    We report the case of a 46-year-old female patient who developed a subacute progression of axial and proximal muscle weakness. Laboratory findings revealed mildly elevated serum creatine kinase levels. No monoclonal gammopathy was detected. A muscle biopsy revealed that she had nemaline myopathy. Serological tests and a lip biopsy revealed Sjögren's syndrome (SjS). We diagnosed her as having sporadic late-onset nemaline myopathy without monoclonal gammopathy of undetermined significance associated with SjS. Her symptoms improved after methylprednisolone pulse therapy followed by intravenous immunoglobulin therapy. A good response to immunotherapy demonstrates the necessity of making a correct diagnosis, for which a muscle biopsy is required.

    Download PDF (587K)
  • Go Endo, Sachiko Kanai, Hiroto Nishio, Hideki Hashimoto, Yoshimi Higur ...
    2024Volume 63Issue 19 Pages 2689-2693
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    We herein present the first known case of bacteremia caused by Kluyvera georgiana in a 67-year-old female undergoing chemotherapy for recurrent pancreatic cancer. The patient underwent choledochojejunotomy and thereafter developed ascending cholangitis. The diagnosis of K. georgiana was confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A literature review of Kluyvera spp. infections indicated potential risk factors including an underlying malignancy and immunosuppression. Although Kluyvera spp. infections are typically sensitive to antibiotics, multidrug resistance is possible. This case highlights the importance of the early diagnosis and treatment of K. georgiana and its associated risk factors.

    Download PDF (364K)
  • Yuya Kobayashi, Kazuki Kasuga, Yusaku Shimizu, Yoshiki Sekijima
    2024Volume 63Issue 19 Pages 2695-2697
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    We report the case of an 80-year-old man with Frey syndrome that developed 30 years postoperatively, which is an exceptionally long period before its occurrence. Sweating and flushing occurred on only the side of his face where the surgery was performed, and he had no other causative abnormalities. Following treatment with botulinum toxin, the patient's symptoms resolved. Extremely early- and late-onset cases do not fit the conventional paradigm of this pathology. Various surgical methods to prevent this syndrome have been explored, but complete prevention has not yet been achieved. These findings suggest that the underlying pathophysiology of Frey syndrome may be more complex than previously recognized.

    Download PDF (477K)
  • Hideshige Seki, Kensuke Narukawa, Yurika Mitsui, Yukari Shirasugi, Shi ...
    2024Volume 63Issue 19 Pages 2699-2701
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    An 83-year-old man diagnosed with multiple myeloma presented with renal failure and hyperkalemia. The patient was treated with calcium polystyrene sulfonate (CPS: kalimate) for hyperkalemia. On the 10th day after starting CPS, airway obstruction due to the presence of a mass was observed, and the patient died on that same day. Autopsy revealed that the mass was located between the trachea and epiglottis and it was determined to consist of CPS-related mosaic crystals. There was a protrusion within the trachea surrounding the CPS crystals, inflammatory cells, and granulation tissue. This case suggests that CPS is associated with not only gastrointestinal complications, but also with airway complications.

    Download PDF (722K)
  • Kohei Yamamoto, Shinsuke Shiotsu, Misaki Sasakura, Shunya Tanaka, Shih ...
    2024Volume 63Issue 19 Pages 2703-2707
    Published: October 01, 2024
    Released on J-STAGE: October 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Combination therapy with ipilimumab and nivolumab is indicated for many types of cancers; however, several patients experience immune-related adverse events (irAEs). We herein report a case of cytokine release syndrome (CRS) in a 63-year-old woman with stage IV left clear cell renal cell carcinoma. Our patient developed CRS while taking prednisolone, 43 days after the start of ipilimumab and nivolumab administration. The patient was treated with steroid pulse therapy, which improved the symptoms of shock and respiratory failure. Increased vascular permeability and relative adrenal insufficiency are considered to be the main pathogeneses. The early administration of high-dose steroids is crucial as a replacement for corticosteroids.

    Download PDF (859K)
PICTURES IN CLINICAL MEDICINE
LETTERS TO THE EDITOR
feedback
Top